In addition to their antithrombotic properties, P2Y12 inhibitors can therefore be considered to have valuable pharmacological targets for inflammation, and the beneficial effects of anti-P2Y12 drugs have been reported for several experimental and clinical inflammatory diseases, including sepsis, acute lung injury, asthma, atherosclerosis, and cancer. Here, P2RY12 is linked to Sepsis.